Athersys Overview
- Year Founded
-
1995
- Status
-
Acquired/Merged
- Employees
-
24
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.75M
Athersys General Information
Description
Athersys Inc is a biotechnology company engaged in the field of regenerative medicine. It consists of research, clinical development, manufacturing, and manufacturing process development activities. The firm's main product is Multistem cell therapy. Its clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and certain pulmonary conditions. Its revenue has been derived from corporate collaborations, license agreements, and government grants.
Contact Information
Website
www.athersys.com(Operating Subsidiary)
Corporate Office
- 3201 Carnegie Avenue
- Cleveland, OH 44115
- United States
Corporate Office
- 3201 Carnegie Avenue
- Cleveland, OH 44115
- United States
Athersys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 17. Merger/Acquisition | 04-Apr-2024 | $1.75M | Completed | Generating Revenue | ||
| 16. Bankruptcy: Admin/Reorg | 05-Jan-2024 | Completed | Bankruptcy: Admin/Reorg | |||
| 15. 2PO | 21-Aug-2023 | Completed | Generating Revenue | |||
| 14. PIPE | 10-Nov-2022 | Completed | Generating Revenue | |||
| 13. 2PO | 17-Apr-2020 | Completed | Generating Revenue | |||
| 12. PIPE | 30-Apr-2018 | Completed | Generating Revenue | |||
| 11. 2PO | 27-Jan-2017 | Completed | Generating Revenue | |||
| 10. Secondary Transaction - Open Market | 15-Jan-2014 | Completed | Generating Revenue | |||
| 9. PIPE | 26-Oct-2012 | $23M | $32M | Completed | Generating Revenue | |
| 8. PIPE | 22-Mar-2012 | $9M | $9M | Completed | Generating Revenue |
Athersys Comparisons
Industry
Financing
Details
Athersys Competitors (49)
One of Athersys’s 49 competitors is Vericel, a Formerly PE-Backed company based in Burlington, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Vericel | Formerly PE-Backed | Burlington, MA | ||||
| Kainova Therapeutics | Venture Capital-Backed | Montreal, Canada | ||||
| Lineage Cell Therapeutics | Corporation | Carlsbad, CA | ||||
| Novavax | Corporation | Gaithersburg, MD | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA |
Athersys Patents
Athersys Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260224441-A1 | Cryostorage devices and methods | Pending | 16-Jan-2023 | ||
| WO-2024155498-A1 | Cryostorage devices and methods | Inactive | 16-Jan-2023 | ||
| WO-2023081420-A1 | Culture-expanded canine progenitor cells and related methods | Inactive | 05-Nov-2021 | ||
| CA-3176381-A1 | Treatment of virus-induced acute respiratory distress syndrome | Pending | 23-Apr-2020 | ||
| WO-2021217098-A1 | Treatment of virus-induced acute respiratory distress syndrome | Inactive | 23-Apr-2020 | A61K35/545 |
Athersys Signals
Athersys Former Investors (39)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Accipiter Capital Management | Hedge Fund | Minority | ||
| BTHC VI | Special Purpose Acquisition Company (SPAC) | Minority | ||
| BVF Partners | Hedge Fund | Minority | ||
| Blue Chip Venture Company | Venture Capital | Minority | ||
| Chelsey Capital | Hedge Fund | Minority |
Athersys Acquisitions (1)
Athersys’s most recent deal was a Merger/Acquisition with BTHC VI. The deal was made on 08-Jun-2007.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| BTHC VI | 08-Jun-2007 | Merger/Acquisition | Special Purpose Acquisition Company (SPAC) |
Athersys ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Pharmaceuticals
Industry
Rank
Percentile
Biotechnology
Subindustry
Rank
Percentile
Athersys FAQs
-
When was Athersys founded?
Athersys was founded in 1995.
-
Where is Athersys headquartered?
Athersys is headquartered in Cleveland, OH.
-
What is the size of Athersys?
Athersys has 24 total employees.
-
What industry is Athersys in?
Athersys’s primary industry is Biotechnology.
-
Is Athersys a private or public company?
Athersys is a Private company.
-
What is the current valuation of Athersys?
The current valuation of Athersys is .
-
What is Athersys’s current revenue?
The current revenue for Athersys is .
-
How much funding has Athersys raised over time?
Athersys has raised $2.25M.
-
Who are Athersys’s investors?
Accipiter Capital Management, BTHC VI, BVF Partners, Blue Chip Venture Company, and Chelsey Capital are 5 of 39 investors who have invested in Athersys.
-
Who are Athersys’s competitors?
Vericel, Kainova Therapeutics, Lineage Cell Therapeutics, Novavax, and Alnylam Pharmaceuticals are some of the 49 competitors of Athersys.
-
When was Athersys acquired?
Athersys was acquired on 04-Apr-2024.
-
Who acquired Athersys?
Athersys was acquired by Healios (Drug Discovery).
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process